top of page

DASH STARTUP: NCSU startup nets $2M for next-gen clotting, bleeding control drugs.
binarypublish
Thursday, March 21, 2024
Raleigh-based startup, Helixomer, has secured a $2 million federal grant for the advancement of two novel drugs aimed at regulating bleeding and clotting in patients.
Read the full article: https://dashstartup.com/blog/ncsu-startup-nets-2m-for-next-gen-clotting-bleeding-control-drugs/
bottom of page
